Sign Out
Levisat is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy.
Levisat is indicated as adjunctive therapy for the following: In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy; In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy; In the treatment of primary generalized tonic-clonic seizures in adults and children from 12 years of age with Idiopathic Generalized Epilepsy.
Infusion conc: Levisat Concentrate is an alternative for patients (adults and children from 4 years of age) when oral administration is not feasible.
